Genome-wide siRNA screen reveals coupling between mitotic apoptosis and adaptation

Laura A Díaz-Martínez1, Zemfira N Karamysheva1, Ross Warrington1

  • 1Department of Pharmacology, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.

The EMBO Journal
|July 16, 2014
PubMed

Insights

Anti-cancer drugs like taxol cause mitotic arrest. This study identifies key players in cancer cell apoptosis and adaptation pathways, revealing crosstalk between them.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Antimitotic drugs, such as taxol, disrupt spindle dynamics, leading to mitotic arrest in cancer cells.
  • Cancer cells in mitotic arrest can undergo apoptosis or adapt and exit mitosis without proper division.

Purpose of the Study:

  • To systematically identify components of the mitotic adaptation and apoptosis pathways using a genome-wide screen.
  • To elucidate the roles of specific proteins, including p31(comet) and Noxa, in these pathways.

Main Methods:

  • Genome-wide small interfering RNA (siRNA) screen in taxol-treated HeLa cells.
  • Analysis of protein degradation (cyclin B1) and apoptotic signaling.

Main Results:

  • p31(comet) promotes mitotic adaptation via cyclin B1 degradation and has a minor role in suppressing apoptosis.
  • Noxa is crucial for initiating mitotic cell death.
  • Unexpectedly, mitochondrial apoptosis pathway components and Drp1 contribute to mitotic adaptation.

Conclusions:

  • Mitotic arrest involves distinct but interconnected apoptosis and adaptation pathways.
  • Crosstalk exists between mitochondrial apoptosis machinery and mitotic adaptation mechanisms.